40th Advances in Gastroenterology
Planned by Jefferson experts, Robert M. Coben, MD, Anthony Infantolino, MD and members of the healthcare team, this one day, in-person conference, now in its fortieth year, will provide participants with the tools that can readily be implemented in daily practice. The program will feature presentations on esophageal/gastroduodenal disorders, small bowel and colonic disorders, advances in gastroenterology, and liver disease.
Learning interests will be matched with updates on the latest clinical trial data, current and emerging treatment strategies, and case-based panel discussions. Gastroenterologists, internist, surgeons, primary care providers, nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with GI disorders are invited to attend.
This course is designed for the gastroenterologists, internist, surgeons, primary care providers, nurse practitioners, physician assistants, nurses, and other healthcare professionals who treat patients with various gastrointestinal disorders.
Preliminary Program Agenda & Learning Objectives

A block of rooms has been reserved for conference attendees. The group rate of $179 per night plus tax is available through Friday, June 1, 2022. Click here to book.
Travel
CLICK HERE for directions and parking information.
Financial Relationships
Thomas Jefferson University endorses the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards. All planners, faculty, authors, presenters, and content reviewers are required to disclose any financial relationships with ACCME defined commercial interest entities within the past 24 months. Any conflict of interests have been mitigated prior to the educational activity.
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the US FDA for the treatment of disease(s).
Such disclosures will be available prior to the start of the activity. Jefferson Conflict of Interest resolution process may result in changes to the program agenda.
Planning Committee
None of the planners have any financial relationships to disclose.
Robert M. Coben, MD
Anthony Infantolino, MD
Emily Rubin, RD
Danielle Bornstein, RN
Faculty
Alex Schlacterman, MD
Daniel Ringold, MD
Colin Smith, MD
The following faculty have no financial relationships to disclose.
Jesse Civan, MD
Robert M. Coben, MD
Anthony Infantolino, MD
Christina Tofani, MD
Christopher Adkins, MD
Stephanie Moleski, MD
Cuckoo Choudhary, MD
Charles Yeo, MD
David Sass, MD
The following faculty have financial relationships to disclose.
Dina Halegoua-DeMarzio
Researcher: Aramchol, BMS, Intercept, Viking; Consultant: Intercept
David Kastenberg, MD
Advisor: Exact Sciences, Medtronic; Researcher: Exact Sciences, Freenome, Medtronic; Consultant: Medtronic
David Loren, MD
Consultant: Boston Scientific, Olympus America, Pinnacle Biologics; Advisor: Olympus American
Raina Shivashankar, MD
Research/Speaker: Abbvie; IBD Fellowship Funding: Janssen Pharmaceuticals
Off‐label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).
Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physicians: This educational activity is designated for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity awards 8.0 nursing contact hours.
Registered Dietitians: This activity awards 8.0 contact hours.
Other Healthcare Professionals: This educational activity is designated for 8.0 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Other Credit
PA Patient Safety and Risk credit: This educational activity offers 1.25 credits. The following session qualifies: Lunch with Keynote Lecture: Colon Cancer Screening/Prevention/New Tools
Nurse Pharmacology credit: This educational activity offers 3.75 credits. The following sessions qualify:
- Diverticulitis: Update on New Guidelines
- Evaluation and Management of Pelvic Floor Disorders
- Role of Drug Monitoring in the Patient with Inflammatory Bowel Disease (IBD)
- Update on Small Bowel Bleeding
- Controversies in the Management of Cystic Lesions of the Pancreas
- Non-alcoholic Fatty Liver Disease (NAFLD): Diagnosis, Management and Emerging Therapies
ABCGN credit: This educational activity has been approved for 7.35 credits by the American Board of Certification for Gastroenterology Nurses (ABCGN). According to the American Board of Certification for Gastroenterology Nurses (ABCGN), the approved hours in this activity are considered GI Specific for the purpose of recertification by contact hours through ABCGN. ABCGN #ABCGN22_023
Available Credit
- 8.00 AMA PRA Category 1 Credit™
- 8.00 Attendance
- 8.00 CDR
- 8.00 CNE
- 3.75 CNE Pharmacotherapy
- 1.25 Patient Safety
Exhibit opportunities are available for this conference. For more information, please contact Ariel Levine at ariel.levine@jefferson.edu.
Price
REGISTRATION FEES
Profession/Affiliation | Ealybird Rate (register before May 27) | Regular Rate (register after May 28) |
---|---|---|
Practicing Physician | $170 | $195 |
Nurse/Other Healthcare Professional | $125 | $140 |
Jefferson Digestive Disease Network Member* | $130 | |
Non-Jefferson Resident/ Fellow | $70 | $80 |
Industry | $199 | |
Jefferson Health/ Enterprise Physicians | $100 | |
Jefferson Health/ Enterprise Nurse/Other Healthcare Professional | $50 | |
Jefferson Health/ Enterprise Residents/ Fellows* | Complimentary |
*Subject to verification.
HOW TO REGISTER |
---|
IMPORTANT DEADLINES:
To register online, you must have a CPD @ JeffLearn account.
|
NOTICE – Unauthorized recording, taping, photographing at Jefferson CE activities is strictly prohibited. If found recording, you will be asked to leave and any registration fees will not be refunded.